| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/02/2001 | WO2001014584A3 Methods of identifying anti-viral agents |
| 08/02/2001 | WO2001014548A3 New g-protein coupled receptor and dna sequences thereof |
| 08/02/2001 | WO2001012797A3 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 08/02/2001 | WO2001012189A8 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/02/2001 | WO2001005424A3 Multi-component vaccine to protect against disease caused by haemophilus influenzae and moraxella catarrhalis |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | WO2001000234A3 Methods and compositions for engineering of attenuated vaccines |
| 08/02/2001 | WO2000067801A3 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/02/2001 | WO2000055191A3 Recombinant haemophilus influenzae adhesin proteins |
| 08/02/2001 | WO2000047625A3 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 08/02/2001 | US20010011124 Genetic engineering |
| 08/02/2001 | US20010011086 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 08/02/2001 | US20010011077 Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides |
| 08/02/2001 | US20010011072 Skin disorders; kidney and liver disorders |
| 08/02/2001 | US20010010934 Polypeptides that regulate epithelial specific gene expression; hypoproliferative disorders; medical diagnosis |
| 08/02/2001 | US20010010933 Configuration; vectors; recombinants |
| 08/02/2001 | US20010010924 Inflammation, arthritis, septicemia, brain injury, autoimmune (inflammatory bowel, psoriasis)/bone/acute respiratory diseases, restenosis, AIDS, cancer (lympho-proliferative disorders, atheroscleosis, and Alzheimer's |
| 08/02/2001 | US20010010913 Isolated polypeptide |
| 08/02/2001 | US20010010821 For treatment of gastrointestinal disorders |
| 08/02/2001 | US20010010819 Septicemia |
| 08/02/2001 | DE10004157A1 New pyridyl- or pyrimidinyl-substituted bicyclic pyrrole derivatives, are cyclokine release inhibitors useful for treating immune system-related disorders, e.g. cancer, multiple sclerosis or arthritis |
| 08/02/2001 | CA2401590A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 08/02/2001 | CA2398728A1 Novel melanocortin receptor agonists and antagonists |
| 08/02/2001 | CA2398561A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 08/02/2001 | CA2398548A1 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | CA2398481A1 Novel carbapenem derivatives |
| 08/02/2001 | CA2398478A1 Novel quaternary salt-type carbapenem derivatives |
| 08/02/2001 | CA2398466A1 Ultra high affinity neutralizing antibodies |
| 08/02/2001 | CA2398430A1 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | CA2398428A1 Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions |
| 08/02/2001 | CA2398173A1 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases |
| 08/02/2001 | CA2398139A1 Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha |
| 08/02/2001 | CA2397998A1 Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infection |
| 08/02/2001 | CA2397831A1 Enhanced propertied pharmaceuticals |
| 08/02/2001 | CA2397754A1 Nitrate salts of antimicrobial agents |
| 08/02/2001 | CA2396884A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
| 08/02/2001 | CA2396709A1 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 08/02/2001 | CA2396640A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | CA2396454A1 Recombinant attenuation of prrsv |
| 08/01/2001 | EP1120464A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 08/01/2001 | EP1120118A1 Preventives/remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters |
| 08/01/2001 | EP1119643A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-$g(a) (TNF-$g(a)) EXPRESSION |
| 08/01/2001 | EP1119630A1 Nucleic acid constructs for genetic immunisation |
| 08/01/2001 | EP1119629A2 Oxidoreductase molecules |
| 08/01/2001 | EP1119620A2 Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses |
| 08/01/2001 | EP1119619A2 Nlk1 -interacting proteins |
| 08/01/2001 | EP1119573A2 Bipyridine manganese complexes |
| 08/01/2001 | EP1119568A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 08/01/2001 | EP1119567A1 Quinazoline derivatives |
| 08/01/2001 | EP1119555A1 Biphenylene lactams as prostaglandin receptor ligands |
| 08/01/2001 | EP1119550A1 2-substituted heterocyclic sulfonamides |
| 08/01/2001 | EP1119539A1 A process for the preparation of 4,4'-dihalogen-o-hydroxydiphenyl compounds |
| 08/01/2001 | EP1119370A1 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 08/01/2001 | EP1119362A1 Method of using tetracycline compounds to enhance interleukin-10 production |
| 08/01/2001 | EP1119354A1 Peripherally acting anti-pruritic opiates |
| 08/01/2001 | EP1119353A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 08/01/2001 | EP1119248A1 Hydroxystilbene compounds used as microbicidal active substances |
| 08/01/2001 | EP0885013B1 Use of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses for the preparation of medicaments |
| 08/01/2001 | EP0740703B1 Diagnosis and treatment of infections due to streptococci and enterococci |
| 08/01/2001 | EP0656946B1 Immunoglobulins devoid of light chains |
| 08/01/2001 | EP0625984B1 Cephalosporin compounds |
| 08/01/2001 | EP0538283B2 Synthetic peptides and mixtures thereof for detecting hiv antibodies |
| 08/01/2001 | CN1306575A Prodn of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 08/01/2001 | CN1306536A Propenyl cephalosporin derivatives |
| 08/01/2001 | CN1306528A Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, its prodn. method and applications |
| 08/01/2001 | CN1306515A Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer |
| 08/01/2001 | CN1306512A Heterocyclic inhibitors of P38 |
| 08/01/2001 | CN1306439A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 08/01/2001 | CN1306437A Vaccine |
| 08/01/2001 | CN1306433A Use of chemically-stabilized chlorite solution for inhibiting antigen-specific immune response |
| 08/01/2001 | CN1306428A Inhibitors of transcription factor NF-KB |
| 08/01/2001 | CN1306425A Process for synthesizing Cox-2 inhibitors |
| 08/01/2001 | CN1306400A Drinks and foods capable of eliminating helicobacter pylori |
| 08/01/2001 | CN1305843A Exterior-applied Chinese-medicinal plaster for treating bone tuberculosis and its preparing process |
| 08/01/2001 | CN1305823A Immunoregulator for preventing and treating AIDS |
| 08/01/2001 | CN1305813A Nail health disinfecting liquid |
| 08/01/2001 | CN1069049C Liquid for treating beriberi |
| 08/01/2001 | CN1069045C Oral liquid curing AIDS and its preparing method |
| 08/01/2001 | CN1069044C Injection for AIDS and prepn. thereof |
| 07/31/2001 | US6268490 Bicyclonucleoside and oligonucleotide analogues |
| 07/31/2001 | US6268488 Active therapeutic agent attached to blocking moiety that is sensitive to catalytic action of molecules having retro-aldol and retro-michael catalytic activity; targeted antitumor, cytotoxic and antibiotic therapy |
| 07/31/2001 | US6268477 Amino acid sequence; detection and treatment of atherosclerosis, rheumatoid arthritis, asthma, aids (acquired immune deficiency syndrome); viricides; antiinflammatory agents; antitumor agents; antiarthritic agents |
| 07/31/2001 | US6268472 Modified HGP-30 peptides, conjugates, compositions and methods of use |
| 07/31/2001 | US6268411 Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 07/31/2001 | US6268395 Phorbol derivatives having antivirus activity |
| 07/31/2001 | US6268382 Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredients |
| 07/31/2001 | US6268379 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 07/31/2001 | US6268357 Organic vanadium (III) complexes and their use |
| 07/31/2001 | US6268346 Having high biological activity of the same type as the known natural compound bpc, but with shorter amino acid chains. |
| 07/31/2001 | US6268344 Associated with sepsis, purpura fulminans, meningococcal sepsis, bone marrow and other transplantations, severe burns, pregnancy, major surgery, severe trauma, or ards. |
| 07/31/2001 | US6268342 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/31/2001 | US6268338 Cyclohexapeptidyl amine compounds |
| 07/31/2001 | US6268337 Methods for treating vascular disorders using activated protein C |
| 07/31/2001 | US6268207 Resolution of enantiomers from a mixture of (1r,2s)/(1s,2s)-1-amino-2-vinylcyclopropyl carboxylic acid methyl ester comprising the step of treating said mixture with an esterase to obtain the corresponding (1r,2s) enantiomer |
| 07/31/2001 | US6268177 An isolated polynucleotide; therapy and treatment of streptococcal infections, pneumonia, meningitis, sinusitis, conjunctivitis; screening for antibiotics |
| 07/31/2001 | US6268172 A polynucleotide encoding a polypeptide for histidine kinase; screening and development of antibiotics for streptococcal diseases; otitis media, conjunctivitis, pneumonia, bacteremia pleural empyema, menegitis, sinusitis |
| 07/31/2001 | US6268171 Recombinant PilC proteins, methods for producing them and their use |
| 07/31/2001 | US6267967 Virus preparations and methods |
| 07/31/2001 | US6267966 Vaccine production of the Bacillus anthracis protective antigen |
| 07/31/2001 | US6267961 Direct methods for molar-mass determination of fragments of Haemophilus influenzae type b capsular polysaccharides and vaccine preparation |